CN101550455B - 人副流感病毒分型及定量检测试剂盒 - Google Patents
人副流感病毒分型及定量检测试剂盒 Download PDFInfo
- Publication number
- CN101550455B CN101550455B CN2008100271065A CN200810027106A CN101550455B CN 101550455 B CN101550455 B CN 101550455B CN 2008100271065 A CN2008100271065 A CN 2008100271065A CN 200810027106 A CN200810027106 A CN 200810027106A CN 101550455 B CN101550455 B CN 101550455B
- Authority
- CN
- China
- Prior art keywords
- reaction tubes
- pcr
- hpiv2
- hpiv1
- hpiv3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 73
- 208000002606 Paramyxoviridae Infections Diseases 0.000 title claims abstract description 60
- 238000001514 detection method Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 43
- 238000003757 reverse transcription PCR Methods 0.000 claims abstract description 42
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
- 239000000523 sample Substances 0.000 claims description 85
- 230000003321 amplification Effects 0.000 claims description 65
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 65
- 238000012360 testing method Methods 0.000 claims description 63
- 238000003908 quality control method Methods 0.000 claims description 43
- 239000012925 reference material Substances 0.000 claims description 32
- 230000002441 reversible effect Effects 0.000 claims description 32
- 108091033319 polynucleotide Proteins 0.000 claims description 27
- 102000040430 polynucleotide Human genes 0.000 claims description 27
- 239000002157 polynucleotide Substances 0.000 claims description 27
- 102000004190 Enzymes Human genes 0.000 claims description 25
- 108090000790 Enzymes Proteins 0.000 claims description 25
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 22
- 238000012544 monitoring process Methods 0.000 claims description 13
- 238000010791 quenching Methods 0.000 claims description 13
- 230000000171 quenching effect Effects 0.000 claims description 13
- 239000011535 reaction buffer Substances 0.000 claims description 13
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 11
- 239000002751 oligonucleotide probe Substances 0.000 claims description 11
- 238000012856 packing Methods 0.000 claims description 10
- 230000002103 transcriptional effect Effects 0.000 claims description 10
- 241000726041 Human respirovirus 1 Species 0.000 claims description 9
- 239000002532 enzyme inhibitor Substances 0.000 claims description 7
- 108091092562 ribozyme Proteins 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 3
- 241000712003 Human respirovirus 3 Species 0.000 claims 8
- 241001559187 Human rubulavirus 2 Species 0.000 claims 8
- 238000003375 selectivity assay Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 abstract description 9
- 238000003745 diagnosis Methods 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 239000003814 drug Substances 0.000 abstract 1
- 238000002795 fluorescence method Methods 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 abstract 1
- 239000000047 product Substances 0.000 description 41
- 238000012408 PCR amplification Methods 0.000 description 22
- 238000013459 approach Methods 0.000 description 21
- 238000000338 in vitro Methods 0.000 description 18
- 239000002773 nucleotide Substances 0.000 description 18
- 125000003729 nucleotide group Chemical group 0.000 description 18
- 238000013518 transcription Methods 0.000 description 18
- 230000035897 transcription Effects 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 16
- 238000010839 reverse transcription Methods 0.000 description 15
- 238000012772 sequence design Methods 0.000 description 15
- 102000039446 nucleic acids Human genes 0.000 description 13
- 108020004707 nucleic acids Proteins 0.000 description 13
- 150000007523 nucleic acids Chemical class 0.000 description 13
- 230000004087 circulation Effects 0.000 description 12
- 230000008569 process Effects 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 238000012113 quantitative test Methods 0.000 description 8
- 206010036790 Productive cough Diseases 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 210000003800 pharynx Anatomy 0.000 description 6
- 210000003802 sputum Anatomy 0.000 description 6
- 208000024794 sputum Diseases 0.000 description 6
- 206010057190 Respiratory tract infections Diseases 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000032258 transport Effects 0.000 description 4
- 101100268670 Caenorhabditis elegans acc-3 gene Proteins 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000003149 assay kit Methods 0.000 description 3
- 239000000571 coke Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000013399 early diagnosis Methods 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000013074 reference sample Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000018569 Respiratory Tract disease Diseases 0.000 description 2
- 241001113283 Respirovirus Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000001894 hemadsorption Effects 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 230000001524 infective effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 1
- 208000031504 Asymptomatic Infections Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- -1 MgCl 2 Chemical compound 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 201000010549 croup Diseases 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 239000005549 deoxyribonucleoside Substances 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 229940124551 recombinant vaccine Drugs 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229940031626 subunit vaccine Drugs 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000003805 vibration mixing Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100271065A CN101550455B (zh) | 2008-03-31 | 2008-03-31 | 人副流感病毒分型及定量检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100271065A CN101550455B (zh) | 2008-03-31 | 2008-03-31 | 人副流感病毒分型及定量检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101550455A CN101550455A (zh) | 2009-10-07 |
CN101550455B true CN101550455B (zh) | 2011-08-24 |
Family
ID=41154944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100271065A Active CN101550455B (zh) | 2008-03-31 | 2008-03-31 | 人副流感病毒分型及定量检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101550455B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106591456A (zh) * | 2016-12-22 | 2017-04-26 | 青海大学 | 基于mgb探针分型检测多房棘球蚴及细粒棘球蚴的实时定量pcr方法及检测试剂盒 |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102337352B (zh) * | 2010-07-16 | 2013-08-14 | 中山大学达安基因股份有限公司 | 一种pcr微阵列检测多种流感病毒的试剂盒 |
CN105277693B (zh) * | 2014-08-18 | 2017-02-01 | 董俊 | 人副流感病毒量子点免疫层析分型检测卡及其制备方法和应用 |
CN105441589B (zh) * | 2015-12-21 | 2018-12-21 | 深圳生科原生物股份有限公司 | 人副流感病毒ⅰ、ⅱ、ⅲ、ⅳ型四重pcr检测试剂盒及其检测方法 |
EP4282985A3 (en) * | 2017-03-24 | 2024-02-28 | Gen-Probe Incorporated | Compositions and methods for detecting or quantifying parainfluenza virus |
CN109097497A (zh) * | 2018-08-30 | 2018-12-28 | 郑州安图生物工程股份有限公司 | 一种人副流感病毒三联核酸检测试剂盒 |
CN108998574A (zh) * | 2018-08-30 | 2018-12-14 | 郑州安图生物工程股份有限公司 | 一种人副流感病毒4型核酸检测试剂盒 |
CN114107562B (zh) * | 2021-11-10 | 2024-03-22 | 江汉大学 | 一种人类副流感病毒的mnp标记位点、引物组合物、试剂盒及其应用 |
-
2008
- 2008-03-31 CN CN2008100271065A patent/CN101550455B/zh active Active
Non-Patent Citations (3)
Title |
---|
吴德等.人副流感病毒HPIV多重RT-PCR快速检测方法的建立.《华南预防医学》.2008,第34卷(第1期),第18-21页. * |
徐昌平等.TaqMan-MGB 荧光定量RT-PCR快速检测副流感3型病毒.《中国卫生检验杂志》.2007,第17卷(第2期),第206-208页. * |
赵海龙等.多重实时PCR检测三种呼吸道病毒.《中华微生物学和免疫学杂志》.2007,第27卷(第9期),第856-859页. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106591456A (zh) * | 2016-12-22 | 2017-04-26 | 青海大学 | 基于mgb探针分型检测多房棘球蚴及细粒棘球蚴的实时定量pcr方法及检测试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN101550455A (zh) | 2009-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101550455B (zh) | 人副流感病毒分型及定量检测试剂盒 | |
Lee et al. | Rapid identification of human adenovirus types 3 and 7 from respiratory specimens via multiplex type-specific PCR | |
CN103484565B (zh) | 一种实时荧光rt-pcr检测冠状病毒的试剂盒及其应用 | |
CN103642945B (zh) | 一种含内参照的高灵敏Epstein-Barr病毒荧光定量PCR试剂盒 | |
US8119338B2 (en) | Methods and compositions for detecting rhinoviruses | |
CN101886138A (zh) | 肠道病毒71型、柯萨奇病毒a16型和肠道病毒其它各亚型三色荧光rt-pcr联合检测方法及其试剂盒 | |
CN105018648A (zh) | 一种用于检测呼吸道病毒的试剂盒及其应用 | |
CN113943836B (zh) | 检测引起呼吸道感染的病原体并鉴定病原体种类的组合物、试剂盒、方法及用途 | |
CN102337351A (zh) | 一种流感病毒分型检测试剂盒 | |
CN101760560A (zh) | 一种人巨细胞病毒(hcmv)荧光pcr检测方法 | |
Van Doornum et al. | Development and implementation of real‐time nucleic acid amplification for the detection of enterovirus infections in comparison to rapid culture of various clinical specimens | |
CN107937580A (zh) | 泌尿生殖道微生物检测用的引物和探针、试剂盒及试剂盒的使用方法 | |
CN105441589A (zh) | 人副流感病毒ⅰ、ⅱ、ⅲ、ⅳ型四重pcr检测试剂盒及其检测方法 | |
CN105018488A (zh) | 用于检测呼吸道病毒的试剂盒及其应用 | |
CN108239676A (zh) | 一种副流感病毒一步法荧光分型rt-pcr检测试剂盒 | |
CN112921126A (zh) | 一种人呼吸道合胞病毒分型检测多重RT-qPCR试剂盒、引物探针组合物及其使用方法 | |
CN108411014A (zh) | 鉴别a型和b型牛多杀性巴氏杆菌的双重实时荧光定量pcr的引物和探针以及检测方法 | |
CN101580883B (zh) | 呼吸道合胞病毒实时荧光pcr检测试剂盒 | |
CN103131797B (zh) | 一种博卡病毒实时荧光pcr检测试剂盒及其应用 | |
CN105734172B (zh) | 一种快速检测猪瘟病毒/猪繁殖与呼吸综合征病毒/猪伪狂犬病毒/猪细小病毒的试剂盒 | |
CN103114154A (zh) | 一种鼻病毒实时荧光rt-pcr检测试剂盒及其应用 | |
CN112029901A (zh) | 一种提高核酸扩增反应特异性的试剂、核酸扩增反应液和试剂盒 | |
CN111172320A (zh) | 呼吸道合胞病毒f基因的检测引物、试剂盒及方法 | |
CN114262758B (zh) | 检测新型冠状病毒突变株的试剂盒及检测方法 | |
CN103436638B (zh) | 一种实时荧光rt-pcr检测人星状病毒的试剂盒及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU DA'AN CLINICAL LABORATORY CENTER CO., LT Free format text: FORMER OWNER: DAAN GENE CO., LTD., ZHONGSHAN UNIV. Effective date: 20110622 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510665 NO. 19, XIANGSHAN ROAD, HIGH-TECH. INDUSTRIAL DEVELOPMENT ZONE, GUANGZHOU CITY, GUANGDONG PROVINCE TO: 510665 NO. 6, LIZHISHAN ROAD, SCIENCE CITY, LUOGANG DISTRICT, GUANGZHOU CITY |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20110622 Address after: 510665 6 litchi mountain road, Luogang District Science Town, Guangzhou Applicant after: GUANGZHOU DAAN CENTER FOR CLINICAL LABORATORY CO.,LTD. Address before: 510665 Guangzhou high tech Industrial Development Zone, Guangdong, Xiang Shan Road, No. 19 Applicant before: DAAN GENE CO., LTD. OF SUN YAT-SEN University |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20091007 Assignee: Guangzhou Kaide Finance Leasing Co.,Ltd. Assignor: GUANGZHOU DAAN CENTER FOR CLINICAL LABORATORY Co.,Ltd. Contract record no.: X2020980005927 Denomination of invention: Human parainfluenza virus typing and quantitative detection kit Granted publication date: 20110824 License type: Exclusive License Record date: 20200911 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Human parainfluenza virus typing and quantitative detection kit Effective date of registration: 20200914 Granted publication date: 20110824 Pledgee: Guangzhou Kaide Finance Leasing Co.,Ltd. Pledgor: GUANGZHOU DAAN CENTER FOR CLINICAL LABORATORY Co.,Ltd. Registration number: Y2020980006003 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Guangzhou Kaide Finance Leasing Co.,Ltd. Assignor: GUANGZHOU DAAN CENTER FOR CLINICAL LABORATORY CO.,LTD. Contract record no.: X2020980005927 Date of cancellation: 20231026 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231026 Granted publication date: 20110824 Pledgee: Guangzhou Kaide Finance Leasing Co.,Ltd. Pledgor: GUANGZHOU DAAN CENTER FOR CLINICAL LABORATORY CO.,LTD. Registration number: Y2020980006003 |